Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.77 |
| ▸ | DDX3X | O00571 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374432 | 0.87 | ALDH1A1 (1.00) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| SCHEMBL29557251 | 0.87 | ALDH1A1 (1.00) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| Hydrochloric Acid SCHEMBL2481626 | 0.85 | ALDH1A1 (0.96) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| SCHEMBL1025424 | 0.81 | DDX3X (0.74) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| Formic Acid SCHEMBL11684985 | 0.81 | ALDH1A1 (0.86) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| SCHEMBL1657499 | 0.79 | DDX3X (1.00) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| SCHEMBL30314470 | 0.79 | DDX3X (1.00) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 | |
| SCHEMBL13916102 | 0.79 | KMT2A (0.53) | ALDH1A1SMN1; SMN2MAPTHSD17B10CYP1A2 | |
| SCHEMBL6798003 | 0.77 | ALDH1A1 (0.80) | ALDH1A1DDX3XSMN1; SMN2MAPTHSD17B10 | |
| SCHEMBL33716 | 0.77 | DDX3X (0.74) | ALDH1A1DDX3XSMN1; SMN2MAPTHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530479-B2 | Deuterium-enriched alkyl sulfonamides | DHANOA DALJIT SINGH (US) | 2013-09-10 | — | — | US | disclosed |
| US-20110034479-A1 | Deuterium-enriched alkyl sulfonamides | DHANOA DALJIT SINGH | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034479-A1 | Deuterium-enriched alkyl sulfonamides | HTR2C, HTR2B, HTR2A | ALDH1A1 1659/4885DDX3X 1751/4885SMN1; SMN2 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.